Regulatory Management Staff Division / Division of Clinical Evaluation and Pharmacology/Toxicology / Division of Human Tissue Products / FDA / CBER Office / /
Person
Allen Wensky / Yongjie Zhou / Celia M. Witten / Wei Liang / Ellen Lazarus / Mercedes A. Serabian / Rachael Anatol / Wilson Bryan / Alex Bailey / Stephanie Simek / Basel Assaf / Theresa Chen / Patrick Riggins / Pakwai (Patrick) Au / Richard McFarland / Raj Puri / Jinhua (Jim) Lu / Kimberly Benton / Ying Huang / /
Position
Investigator / individual An IND sponsor-investigator / The IND Review Process Team Concept Regulatory project manager / Biomedical Engineer / Director 3 Pharmacology/Toxicology Staff / Pharmacologist / Deputy Director / Director / Commissioner / Associate Director for Policy / Biologist / Chemist / Toxicologist / Supervisory Toxicologist / /
IND-Enabling Studies: Preclinical Perspective Mercedes A. Serabian, M.S., DABT FDA/CBER/OCTGT/DCEPT/PTB 11th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases